All Relations between Alzheimer Disease and bdnf

Publication Sentence Publish Date Extraction Date Species
Rosy Wang, R M Damian Holsinge. Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia. Ageing research reviews. vol 48. 2019-07-29. PMID:30326283. thus, the proposed link between bdnf, exercise and cognition may have critical therapeutic implications for the prevention and amelioration of memory loss and cognitive impairment in alzheimer's disease and associated dementias. 2019-07-29 2023-08-13 human
Hiroshi Tsuneki, Hitomi Yoshida, Kentaro Okamoto, Misako Yamaguchi, Kosuke Endo, Ayumi Nakano, Masaaki Tsuda, Naoki Toyooka, Tsutomu Wada, Toshiyasu Sasaok. AS1949490, an inhibitor of 5'-lipid phosphatase SHIP2, promotes protein kinase C-dependent stabilization of brain-derived neurotrophic factor mRNA in cultured cortical neurons. European journal of pharmacology. vol 851. 2019-07-22. PMID:30753865. brain-derived neurotrophic factor (bdnf), an essential factor for maintaining brain functions, has been reported to be reduced in various neurological diseases, including alzheimer's disease and major depression. 2019-07-22 2023-08-13 Not clear
Qingnan Zhao, Yaqi Shen, Yanli Zhao, Lining Si, Shan Jiang, Yu Qi. Val66Met Polymorphism in BDNF Has No Sexual and APOE ε4 Status-Based Dimorphic Effects on Susceptibility to Alzheimer's Disease: Evidence From an Updated Meta-Analysis of Case-Control Studies and High-Throughput Genotyping Cohorts. American journal of Alzheimer's disease and other dementias. vol 33. issue 1. 2019-07-17. PMID:28984138. val66met polymorphism in bdnf has no sexual and apoe ε4 status-based dimorphic effects on susceptibility to alzheimer's disease: evidence from an updated meta-analysis of case-control studies and high-throughput genotyping cohorts. 2019-07-17 2023-08-13 Not clear
Qingnan Zhao, Yaqi Shen, Yanli Zhao, Lining Si, Shan Jiang, Yu Qi. Val66Met Polymorphism in BDNF Has No Sexual and APOE ε4 Status-Based Dimorphic Effects on Susceptibility to Alzheimer's Disease: Evidence From an Updated Meta-Analysis of Case-Control Studies and High-Throughput Genotyping Cohorts. American journal of Alzheimer's disease and other dementias. vol 33. issue 1. 2019-07-17. PMID:28984138. some studies showed that val66met polymorphism of brain-derived neurotrophic factor (bdnf) conveys susceptibility to alzheimer's disease (ad) in females only. 2019-07-17 2023-08-13 Not clear
Abhik Sen, Thomas J Nelson, Daniel L Alkon, Jarin Hongpaisa. Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus. Journal of Alzheimer's disease : JAD. vol 63. issue 3. 2019-06-10. PMID:29710707. loss in pkc epsilon causes downregulation of mnsod and bdnf expression in neurons of alzheimer's disease hippocampus. 2019-06-10 2023-08-13 mouse
Ted Kheng Siang Ng, Cyrus Su Hui Ho, Wilson Wai San Tam, Ee Heok Kua, Roger Chun-Man H. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis. International journal of molecular sciences. vol 20. issue 2. 2019-04-23. PMID:30634650. decreased serum brain-derived neurotrophic factor (bdnf) levels in patients with alzheimer's disease (ad): a systematic review and meta-analysis. 2019-04-23 2023-08-13 Not clear
Ted Kheng Siang Ng, Cyrus Su Hui Ho, Wilson Wai San Tam, Ee Heok Kua, Roger Chun-Man H. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis. International journal of molecular sciences. vol 20. issue 2. 2019-04-23. PMID:30634650. findings from previous studies reporting the levels of serum brain-derived neurotrophic factor (bdnf) in patients with alzheimer's disease (ad) and individuals with mild cognitive impairment (mci) have been conflicting. 2019-04-23 2023-08-13 Not clear
Alireza Mohammadi, Vahid Ghasem Amooeian, Ehsan Rashid. Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases. Current gene therapy. vol 18. issue 1. 2019-04-09. PMID:29512462. in this review, we attempted to explore the role of bdnf and its associated pathways in susceptibility to schizophrenia (scz), alzheimer's (ad), and parkinson's (pd) diseases. 2019-04-09 2023-08-13 Not clear
Hui Chen, Larbi Amazit, Marc Lombès, Damien Le Menue. Crosstalk Between Glucocorticoid Receptor and Early-growth Response Protein 1 Accounts for Repression of Brain-derived Neurotrophic Factor Transcript 4 Expression. Neuroscience. vol 399. 2019-03-11. PMID:30578973. altered bdnf expression is associated with many pathologies such as depression, alzheimer's disease and addiction. 2019-03-11 2023-08-13 Not clear
Marta Balietti, Cinzia Giuli, Fiorenzo Cont. Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer's Disease: Are There Methodological Biases? Molecular neurobiology. vol 55. issue 8. 2019-02-26. PMID:29330839. mounting evidence that alterations in brain-derived neurotrophic factor (bdnf) levels and signaling may be involved in the etiopathogenesis of alzheimer's disease (ad) has suggested that its blood levels could be used as a biomarker of the disease. 2019-02-26 2023-08-13 human
Shraddha Sapkota, Roger A Dixo. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers. Journal of Alzheimer's disease : JAD. vol 62. issue 2. 2019-02-08. PMID:29480189. a network of genetic effects on non-demented cognitive aging: alzheimer's genetic risk (clu + cr1 + picalm) intensifies cognitive aging genetic risk (comt + bdnf) selectively for apoeɛ4 carriers. 2019-02-08 2023-08-13 Not clear
Marco Túlio Gualberto Cintra, Rafaela Teixeira Ávila, Thayana Oliveira Soares, Luciana Cristina Matos Cunha, Katia Daniela Silveira, Edgar Nunes de Moraes, Kaique Roger Simas, Renato Bragança Fernandes, Denise Utsch Gonçalves, Nilton Alves de Rezende, Maria Aparecida Camargos Bicalh. Increased N200 and P300 latencies in cognitively impaired elderly carrying ApoE ε-4 allele. International journal of geriatric psychiatry. vol 33. issue 2. 2019-01-25. PMID:28833437. to compare the results of neuropsychological tests, evoked potentials n200 and p300 and polymorphisms of apoe and bdnf rs6265 between patients with normal cognition and those with mild cognitive impairment (mci) and alzheimer's dementia (ad). 2019-01-25 2023-08-13 Not clear
Gorka Gerenu, Eva Martisova, Hilda Ferrero, Miguel Carracedo, Tomi Rantamäki, Maria Javier Ramirez, Francisco Javier Gil-Be. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits. Biochimica et biophysica acta. Molecular basis of disease. vol 1863. issue 4. 2018-11-19. PMID:28132883. modulation of bdnf cleavage by plasminogen-activator inhibitor-1 contributes to alzheimer's neuropathology and cognitive deficits. 2018-11-19 2023-08-13 mouse
Se Hoon Choi, Enjana Bylykbashi, Zena K Chatila, Star W Lee, Benjamin Pulli, Gregory D Clemenson, Eunhee Kim, Alexander Rompala, Mary K Oram, Caroline Asselin, Jenna Aronson, Can Zhang, Sean J Miller, Andrea Lesinski, John W Chen, Doo Yeon Kim, Henriette van Praag, Bruce M Spiegelman, Fred H Gage, Rudolph E Tanz. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model. Science (New York, N.Y.). vol 361. issue 6406. 2018-11-14. PMID:30190379. combined adult neurogenesis and bdnf mimic exercise effects on cognition in an alzheimer's mouse model. 2018-11-14 2023-08-13 mouse
Heikki Tanil. The role of BDNF in Alzheimer's disease. Neurobiology of disease. vol 97. issue Pt B. 2018-10-29. PMID:27185594. the role of bdnf in alzheimer's disease. 2018-10-29 2023-08-13 Not clear
Alan H Nagahara, Bayard R Wilson, Iryna Ivasyk, Imre Kovacs, Saytam Rawalji, John R Bringas, Phillip J Pivirotto, Waldy San Sebastian, Lluis Samaranch, Krystof S Bankiewicz, Mark H Tuszynsk. MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene therapy. vol 25. issue 2. 2018-10-11. PMID:29535375. brain-derived neurotrophic factor (bdnf) gene delivery to the entorhinal cortex is a candidate for treatment of alzheimer's disease (ad) to reduce neurodegeneration that is associated with memory loss. 2018-10-11 2023-08-13 Not clear
Burak Yulug, Lutfu Hanoglu, Elmir Khanmammadov, Ozge Arici Duz, Burcu Polat, Taha Hanoglu, Mehmet Yalcin Gunal, Ertugrul Kili. Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF? : A Minireview. Mini reviews in medicinal chemistry. vol 18. issue 17. 2018-09-27. PMID:28971775. beyond the therapeutic effect of rtms in alzheimer's disease: a possible neuroprotective role of hippocampal bdnf? 2018-09-27 2023-08-13 Not clear
Burak Yulug, Lutfu Hanoglu, Elmir Khanmammadov, Ozge Arici Duz, Burcu Polat, Taha Hanoglu, Mehmet Yalcin Gunal, Ertugrul Kili. Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF? : A Minireview. Mini reviews in medicinal chemistry. vol 18. issue 17. 2018-09-27. PMID:28971775. additionally, we have also evaluated the role of magnetic resonance spectroscopy in monitoring the bdnf response after rtms application in alzheimer's disease. 2018-09-27 2023-08-13 Not clear
Nurgul Aytan, Ji-Kyung Choi, Isabel Carreras, Leah Crabtree, Brian Nguyen, Margaret Lehar, Jan Krzysztof Blusztajn, Bruce G Jenkins, Alpaslan Dedeogl. Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease. European journal of pharmacology. vol 828. 2018-09-19. PMID:29510124. interest in brain-derived neurotrophic factor (bdnf) was greatly enhanced when it was recognized that its expression is reduced in neurodegenerative disorders, especially in alzheimer's disease (ad). 2018-09-19 2023-08-13 mouse
Jun Zhang, Zanchao Liu, Yuanyuan Pei, Wen Yang, Chicu Xie, Shiqi Lon. MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor. Neurochemical research. vol 43. issue 3. 2018-08-30. PMID:29464486. brain-derived neurotrophic factor (bdnf) is a crucial regulator to support synaptic plasticity and neuronal survival, its significant decrease is a pathophysiological hallmark in alzheimer's disease (ad) brains and accounts for poor prognosis. 2018-08-30 2023-08-13 mouse